Trials / Conditions / HER2-positive Advanced Gastric Cancer
HER2-positive Advanced Gastric Cancer
4 registered clinical trials studyying HER2-positive Advanced Gastric Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junctio NCT05993234 | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | — |
| Recruiting | Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy NCT05640830 | Kangbuk Samsung Hospital | Phase 1 / Phase 2 |
| Unknown | Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer NCT05348161 | Peking University | N/A |
| Unknown | HER2 Positive CTC in Advanced Gastric Cancer NCT01847794 | Peking University | N/A |